Tax money pays for research and researchers at federal and local levels.
Tax money subsidizes teaching hospitals, and in the process generates guinea pigs for doctors to learn on.
NIH (and other national research facilities in other countries) are primary inventors and developers of pharmaceuticals
Tax money subsidizes the education of healthcare workers from doctor to janitor.
Hospitals get an institutional exemption from property taxes, even for-profit hospitals.
The federal government and state and local governments own and operate hospitals through various health care delivery systems including but not limited to public hospitals, the VA, and military hospitals.
Frankly, it's the people and places with the biggest mouths on secession which would be hurt the most by it. While Texas is the exception in federal aid, all the other southern states are beggar states. Moreover, the concentration of military bases in the South means that huge federal payrolls go to places where the entire economy is peripheral to a military base.
Since 80% of the country didn't want Obamacare. I think this needs to be addressed. The government over stepped its bounds by passing it know such was the case. And even Justice Roberts said it was unconstitutional, which is why he stated it as a tax to be passed by the SCOTUS.
My only thought is that Holder and Obama are going to be suing the state of South Carolina now for not allowing a socialist agenda that ALL liberals love go through. Well, I can't say all liberals. Even Harry Reid is saying that Obamacare is crap.
The Most Productive Drug Companies Of The Past 10 Years
11 comments, 9 called-out Comment Now
Over the past 10 years, 278 new drugs have been approved by the Food and Drug Administration, according to data from the InnoThink Center for Research in Biomedical Innovation. One hundred-and-seventy-five of them, or 63% of those approvals, came from 41 companies that had at least two new drugs approved during that time period. (Specifically, were looking from the beginning of 2003 until now.) Below are all of those 41 companies.
This data gives insight into how productive different drug companies have been over this time period one during which, generally speaking, research and development in the pharmaceutical industry has been below the level it needed to be. Obviously, a count of the number of new molecular entities (industry jargon for brand new drugs) is not the only measure of innovation. A truly great medicine is worth a whole lot of me-too pills. But its a start. Theres a lot more that can be done with this data, but I wanted to get this cut out. To see a similar list from a year or so ago, click here. Here is a 15-year time frame. And here is a 60-year time frame.
Thanks to InnoThink principal Bernard Munos for all his help in collating and analyzing this data.
The Most Productive Drug Firms
Company Number of new drugs
Johnson & Johnson 13
Bristol-Myers Squibb 9
Hoffmann-La Roche 8
CSL Behring 4
Biogen Idec 3
Novo Nordisk 2
Sanofi Aventis 2
Source: InnoThink Center for Research in Biomedical Innovation, FDA
Total Number of All U.S. Registered * Hospitals 5,724
Number of U.S. Community ** Hospitals 4,973
Number of Nongovernment Not-for-Profit Community Hospitals 2,903
Number of Investor-Owned (For-Profit) Community Hospitals 1,025
Number of State and Local Government Community Hospitals 1,045
Number of Federal Government Hospitals 208
Number of Nonfederal Psychiatric Hospitals 421
Number of Nonfederal Long Term Care Hospitals 112
Number of Hospital Units of Institutions (Prison Hospitals, College Infirmaries, Etc.) 10
In short, every one of your arguments is either based on false data or irrelevant to the discussion.
Private pharma firms also hold patents on formulations for drugs that they did not invent or develop. The may have done the end work (clinical trials) but didn't actually save the tenth monkey with brain cancer.
All drugs are not created equal. Thus a figure that private industry invented or parented to patent a given number of drugs is without meaning. Moreover, you still can't separate the money. If Glaxo participates in a development at a research university that is funded by state dollars, and they all are, then you can't say, "Well the lights were paid for by the state on Tuesday and by Glaxo on Monday."